An analyst says Boston Scientific has suspended all sales of its implantable cardioverter defibrillators after finding a documentation error in regulatory filings. Bernstein senior analyst Derrick Sung says in a research note the error puts the Natick, Mass.,…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook




Boston Scientific – Natick Massachusetts – Business – Defibrillation – Natick

See original here:
Analyst: Boston Scientific suspends device sales